Dark Forest Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Dark Forest Capital Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-72,703	Closed	-$1.53M	–	1118
2025 Q4	$1.53M	Buy	+72,703	New	+$1.27M	0.07%	496
2025 Q3	–	Sell	-160,327	Closed	-$1.5M	–	1462
2025 Q2	$1.5M	Buy	160,327 +121,118	+309%	+$1.33M	0.06%	577
2025 Q1	$482K	Buy	+39,209	New	+$553K	0.02%	935
2023 Q2	–	Sell	-502	Closed	-$10.6K	–	1369
2023 Q1	$10.6K	Buy	+502	New	+$12.5K	﹤0.01%	1024
2022 Q3	–	Sell	-65	Closed	-$1K	–	1415
2022 Q2	$1K	Sell	65 -67,365	-100%	-$1.12M	﹤0.01%	821
2022 Q1	$1.17M	Buy	+67,430	New	+$1.14M	0.27%	96

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Dark Forest Capital Management's SNDX Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Syndax Pharmaceuticals (SNDX) in Q1 2026, closing a stake of 72,703 shares — an estimated $1.53M sold.

Dark Forest Capital Management first reported a position in SNDX in Q1 2022 and held it in 6 quarters. The position peaked at $1.53M in Q4 2025. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

Dark Forest Capital Management reported no remaining Syndax Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Dark Forest Capital Management sold 72,703 Syndax Pharmaceuticals shares in Q1 2026, an estimated $1.53M.
Dark Forest Capital Management first reported a position in Syndax Pharmaceuticals in Q1 2022 and held it in 6 quarters.
Dark Forest Capital Management's Syndax Pharmaceuticals position peaked at $1.53M in Q4 2025.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.